| GPMCX | MIDCX | GPMCX / MIDCX | |
| Total Expense Ratio | 2.00 | 2.03 | 99% |
| Annual Report Gross Expense Ratio | 1.99 | 2.04 | 98% |
| Fund Existence | 11 years | 26 years | - |
| Gain YTD | 2.254 | 6.483 | 35% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 45.5M | 7.66B | 1% |
| Annual Yield % from dividends | 1.87 | 0.65 | 289% |
| Returns for 1 year | 2.43 | 5.46 | 45% |
| Returns for 3 years | 29.02 | 17.75 | 163% |
| Returns for 5 years | -22.00 | -9.19 | 239% |
| Returns for 10 years | 60.63 | 25.48 | 238% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LYFCX | 18.46 | 0.47 | +2.61% |
| AlphaCentric Life Sciences & Hlthcare C | |||
| EADIX | 21.62 | 0.15 | +0.70% |
| Eaton Vance Global Equity Income A | |||
| DBORX | 25.53 | 0.03 | +0.12% |
| BNY Mellon Balanced Opportunity I | |||
| BBGSX | 18.09 | -0.20 | -1.09% |
| Bridge Builder Small/Mid Cap Growth | |||
| LADQX | 29.29 | -1.13 | -3.71% |
| Lord Abbett Developing Growth R2 | |||